Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group.

Lancet. 2013 Mar 9;381(9869):805-16. Erratum in: Lancet. 2013 Mar 9;381(9869):804.

2.

Analysis of exhausts emitted by i.c. engines and stationary burners, by means of u.v. extinction and fluorescence spectroscopy.

Merola SS, Gambi G, Allouis C, Beretta F, Borghese A, D'Alessio A.

Chemosphere. 2001 Feb-Mar;42(5-7):827-34.

PMID:
11219709
3.

[Results of the treatment of cancer of the vagina].

Olfos P, Solé J, Gambi G, Baeza R, Suárez E, Campodónico I.

Rev Chil Obstet Ginecol. 1985;50(3):194-200. Spanish. No abstract available.

PMID:
3843272
4.

[Results and prognostic factors in cancer of the uterine cervix].

Olfos P, Gambi G, Solé J, Baeza R, Suárez E, Fernández M, Campodonico I.

Rev Chil Obstet Ginecol. 1985;50(2):113-26. Spanish. No abstract available.

PMID:
3843265
5.

[Treatment of cervix uteri carcinoma. Evaluation of 3 years' experience].

Wild R, Riveros R, Fernández M, Mayerson D, Oyarzún E, Gambi G, Pruyas M, Viñales D.

Rev Chil Obstet Ginecol. 1982;47(2):65-77. Spanish. No abstract available.

PMID:
7167654
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk